
### [MONDO:0019696](http://purl.obolibrary.org/obo/MONDO_0019696)
**Label:** acromesomelic dysplasia

**Subclasses:** [MONDO:0012274](http://purl.obolibrary.org/obo/MONDO_0012274) (acromesomelic dysplasia, Demirhan type), [MONDO:0008717](http://purl.obolibrary.org/obo/MONDO_0008717) (acromesomelic dysplasia, Hunter-Thompson type), [MONDO:0009231](http://purl.obolibrary.org/obo/MONDO_0009231) (fibular hypoplasia and complex brachydactyly), [MONDO:0010881](http://purl.obolibrary.org/obo/MONDO_0010881) (Mesomelia-synostoses syndrome), [MONDO:0011275](http://purl.obolibrary.org/obo/MONDO_0011275) (acromesomelic dysplasia, Maroteaux type), [MONDO:0008703](http://purl.obolibrary.org/obo/MONDO_0008703) (acromesomelic dysplasia, Grebe type), [MONDO:0007219](http://purl.obolibrary.org/obo/MONDO_0007219) (brachydactyly type A6), 

**Mapped go classes:** [GO:2001054](http://purl.obolibrary.org/obo/GO_2001054) (negative regulation of mesenchymal cell apoptotic process), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:0016849](http://purl.obolibrary.org/obo/GO_0016849) (phosphorus-oxygen lyase activity), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0004383](http://purl.obolibrary.org/obo/GO_0004383) (guanylate cyclase activity), [GO:0007178](http://purl.obolibrary.org/obo/GO_0007178) (transmembrane receptor protein serine/threonine kinase signaling pathway), [GO:0001550](http://purl.obolibrary.org/obo/GO_0001550) (ovarian cumulus expansion), [GO:0042698](http://purl.obolibrary.org/obo/GO_0042698) (ovulation cycle), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0001502](http://purl.obolibrary.org/obo/GO_0001502) (cartilage condensation), [GO:0071773](http://purl.obolibrary.org/obo/GO_0071773) (cellular response to BMP stimulus), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0030509](http://purl.obolibrary.org/obo/GO_0030509) (BMP signaling pathway), [GO:0030501](http://purl.obolibrary.org/obo/GO_0030501) (positive regulation of bone mineralization), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process), [GO:0051447](http://purl.obolibrary.org/obo/GO_0051447) (negative regulation of meiotic cell cycle), [GO:0036122](http://purl.obolibrary.org/obo/GO_0036122) (BMP binding), [GO:0008074](http://purl.obolibrary.org/obo/GO_0008074) (guanylate cyclase complex, soluble), [GO:1902043](http://purl.obolibrary.org/obo/GO_1902043) (positive regulation of extrinsic apoptotic signaling pathway via death domain receptors), [GO:0060591](http://purl.obolibrary.org/obo/GO_0060591) (chondroblast differentiation), [GO:0005160](http://purl.obolibrary.org/obo/GO_0005160) (transforming growth factor beta receptor binding), [GO:0007184](http://purl.obolibrary.org/obo/GO_0007184) (SMAD protein import into nucleus), [GO:0060395](http://purl.obolibrary.org/obo/GO_0060395) (SMAD protein signal transduction), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0004675](http://purl.obolibrary.org/obo/GO_0004675) (transmembrane receptor protein serine/threonine kinase activity), [GO:0004702](http://purl.obolibrary.org/obo/GO_0004702) (signal transducer, downstream of receptor, with serine/threonine kinase activity), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0071363](http://purl.obolibrary.org/obo/GO_0071363) (cellular response to growth factor stimulus), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0010862](http://purl.obolibrary.org/obo/GO_0010862) (positive regulation of pathway-restricted SMAD protein phosphorylation), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0006182](http://purl.obolibrary.org/obo/GO_0006182) (cGMP biosynthetic process), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0043408](http://purl.obolibrary.org/obo/GO_0043408) (regulation of MAPK cascade), [GO:1900194](http://purl.obolibrary.org/obo/GO_1900194) (negative regulation of oocyte maturation), [GO:0002062](http://purl.obolibrary.org/obo/GO_0002062) (chondrocyte differentiation), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0042078](http://purl.obolibrary.org/obo/GO_0042078) (germ-line stem cell division), [GO:0045666](http://purl.obolibrary.org/obo/GO_0045666) (positive regulation of neuron differentiation), [GO:0045669](http://purl.obolibrary.org/obo/GO_0045669) (positive regulation of osteoblast differentiation), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0048263](http://purl.obolibrary.org/obo/GO_0048263) (determination of dorsal identity), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0017046](http://purl.obolibrary.org/obo/GO_0017046) (peptide hormone binding), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0035136](http://purl.obolibrary.org/obo/GO_0035136) (forelimb morphogenesis), [GO:0035137](http://purl.obolibrary.org/obo/GO_0035137) (hindlimb morphogenesis), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007168](http://purl.obolibrary.org/obo/GO_0007168) (receptor guanylyl cyclase signaling pathway), [GO:0042562](http://purl.obolibrary.org/obo/GO_0042562) (hormone binding), [GO:0022414](http://purl.obolibrary.org/obo/GO_0022414) (reproductive process), [GO:0045597](http://purl.obolibrary.org/obo/GO_0045597) (positive regulation of cell differentiation), [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity), [GO:0048468](http://purl.obolibrary.org/obo/GO_0048468) (cell development), [GO:0005025](http://purl.obolibrary.org/obo/GO_0005025) (transforming growth factor beta receptor activity, type I), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0006703](http://purl.obolibrary.org/obo/GO_0006703) (estrogen biosynthetic process), [GO:0030513](http://purl.obolibrary.org/obo/GO_0030513) (positive regulation of BMP signaling pathway), [GO:0001654](http://purl.obolibrary.org/obo/GO_0001654) (eye development), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0046332](http://purl.obolibrary.org/obo/GO_0046332) (SMAD binding), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0032331](http://purl.obolibrary.org/obo/GO_0032331) (negative regulation of chondrocyte differentiation), [GO:0032332](http://purl.obolibrary.org/obo/GO_0032332) (positive regulation of chondrocyte differentiation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016941](http://purl.obolibrary.org/obo/GO_0016941) (natriuretic peptide receptor activity), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [GO:0016941](http://purl.obolibrary.org/obo/GO_0016941) (natriuretic peptide receptor activity) 52.00%
- [GO:0005025](http://purl.obolibrary.org/obo/GO_0005025) (transforming growth factor beta receptor activity, type I) 52.00%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) 37.36%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 37.36%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 37.36%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 37.36%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 37.36%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 37.36%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 37.36%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 37.36%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 37.36%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 37.36%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 37.36%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2000745](http://purl.obolibrary.org/obo/GO_2000745) (obsolete positive regulation of transcription from RNA polymerase III promoter involved in smooth muscle cell differentiation)) 37.36%


